Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia — Stella

Recruiting

Back to Cannabis Use trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Vanderbilt Psychiatric Hospital, Nashville, Tennessee

Key details

Sponsor

Vanderbilt University Medical Center

Enrollment target

~100 participants

Started

January 2026

Primary completion

December 2027

Age range

18 Years – 65 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov